Have any questions? 706-721-6582 or cts@augusta.edu
- (ASPIRE) Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery
Clinical Trial
(ASPIRE) Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery
This study is for people who have A-Fib (atrial fibrillation) and recently had a stroke. This study is to see if Eliquis or aspirin is better in preventing strokes and death.
Eligibility Criteria
- Adults who have had an intracranial hemorrhage (ICH) confimed by CT or MRI within 14-120 days of being screened to participate.
RESEARCH. INNOVATION. DISCOVERY.